Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions
出版年份 2015 全文链接
标题
Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions
作者
关键词
-
出版物
PPAR Research
Volume 2015, Issue -, Pages 1-18
出版商
Hindawi Limited
发表日期
2015-10-27
DOI
10.1155/2015/271983
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dietary n-3 PUFA Protects Mice from Con A Induced Liver Injury by Modulating Regulatory T Cells and PPAR-γ Expression
- (2015) Min Lian et al. PLoS One
- Cardiac peroxisome-proliferator-activated receptor expression in hypertension co-existing with diabetes
- (2015) Ting-I Lee et al. CLINICAL SCIENCE
- The First Approved Agent in the Glitazar’s Class: Saroglitazar
- (2014) Ritesh Agrawal CURRENT DRUG TARGETS
- Effect of Aleglitazar on Cardiovascular Outcomes After Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus
- (2014) A. Michael Lincoff et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Minireview: Challenges and Opportunities in Development of PPAR Agonists
- (2014) Matthew B. Wright et al. MOLECULAR ENDOCRINOLOGY
- Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
- (2014) Bogna Grygiel-Górniak Nutrition Journal
- Circadian rhythms, Wnt/beta-catenin pathway and PPAR alpha/gamma profiles in diseases with primary or secondary cardiac dysfunction
- (2014) Yves Lecarpentier et al. Frontiers in Physiology
- Expression of lipogenic genes is upregulated in the heart with exercise training-induced but not pressure overload-induced left ventricular hypertrophy
- (2013) Pawel Dobrzyn et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy
- (2013) T.-I. Lee et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Conditional Deletion of Cardiomyocyte Peroxisome Proliferator-Activated Receptor γ Enhances Myocardial Ischemia-Reperfusion Injury in Mice
- (2013) Michael J. Hobson et al. SHOCK
- Controlling a master switch of adipocyte development and insulin sensitivity: Covalent modifications of PPARγ
- (2012) Z. Elizabeth Floyd et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Targeting Orphan Nuclear Receptors for Treatment of Metabolic Diseases and Autoimmunity
- (2012) Thomas P. Burris et al. CHEMISTRY & BIOLOGY
- PPAR agonists for the treatment of cardiovascular disease in patients with diabetes
- (2012) J. P. H. Wilding DIABETES OBESITY & METABOLISM
- PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty
- (2012) Janice V. Huang et al. JOURNAL OF LIPID RESEARCH
- Anti-inflammatory effect of simvastatin in an experimental model of spinal cord trauma: involvement of PPAR-α
- (2012) Emanuela Esposito et al. Journal of Neuroinflammation
- The nuclear receptor PPARs as important regulators of T-cell functions and autoimmune diseases
- (2012) Je-Min Choi et al. MOLECULES AND CELLS
- Metabolomics
- (2012) Jessica E. Montanez et al. TOXICOLOGIC PATHOLOGY
- Nutraceuticals as Ligands of PPARγ
- (2012) Meera Penumetcha et al. PPAR Research
- PPAR-γ Agonists in Polycystic Kidney Disease with Frequent Development of Cardiovascular Disorders
- (2012) Shizuko Nagao et al. Current Molecular Pharmacology
- The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation
- (2011) Kristine M. Wadosky et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation
- (2011) Tamas Varga et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome
- (2011) Barbara C Hansen et al. Cardiovascular Diabetology
- PPARs and their Effects on the Cardiovascular System
- (2011) Adebayo Oyekan CLINICAL AND EXPERIMENTAL HYPERTENSION
- Antihypertensive Effects of Peroxisome Proliferator-Activated Receptor-β Activation in Spontaneously Hypertensive Rats
- (2011) María José Zarzuelo et al. HYPERTENSION
- Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
- (2011) Ralph A. DeFronzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
- (2011) Alexandra Rogue et al. PLoS One
- Fibrates, Glitazones, and Peroxisome Proliferator–Activated Receptors
- (2010) Fanny Lalloyer et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- PPARβ/δ activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells
- (2010) David Álvarez-Guardia et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Preferential Oxidation of Triacylglyceride-Derived Fatty Acids in Heart Is Augmented by the Nuclear Receptor PPARα
- (2010) Natasha H. Banke et al. CIRCULATION RESEARCH
- Pharmacokinetics, Pharmacodynamics, and Tolerability of Aleglitazar in Patients With Type 2 Diabetes: Results From a Randomized, Placebo-Controlled Clinical Study
- (2010) P Sanwald-Ducray et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Oxidative stress and inflammation modulate peroxisome proliferator-activated receptors with regional discrepancy in diabetic heart
- (2010) Ting-I. Lee et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- The Effects of a PPARα Agonist on Myocardial Damage in Obese Diabetic Mice With Heart Failure
- (2010) Rui Chen et al. International Heart Journal
- Effects of high dose aleglitazar on renal function in patients with type 2 diabetes
- (2010) Matthias Herz et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Targeting Apoptosis in the Heart of Streptozotocin-Induced Diabetic Rats
- (2010) Azza Baraka et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Selective modulation of PPARγ activity can lower plasma glucose without typical thiazolidinedione side-effects in patients with Type 2 diabetes
- (2010) Fredrick L. Dunn et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
- (2010) Jang Hyun Choi et al. NATURE
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- PPARs, Cardiovascular Metabolism, and Function: Near- or Far-from-Equilibrium Pathways
- (2010) Yves Lecarpentier et al. PPAR Research
- Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver
- (2010) Alexandra Rogue et al. PPAR Research
- Coactivators in PPAR-Regulated Gene Expression
- (2010) Navin Viswakarma et al. PPAR Research
- Peroxisome Proliferator-Activated Receptor (PPAR)β /δ: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome
- (2010) Teresa Coll et al. Current Molecular Pharmacology
- Effect of a peroxisome proliferator-activated receptor γ sumoylation mutant on neointimal formation after balloon injury in rats
- (2009) Soo Lim et al. ATHEROSCLEROSIS
- Peroxisome proliferator-activated receptor-γ activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor
- (2009) Sang-Hyun Ihm et al. BASIC RESEARCH IN CARDIOLOGY
- Nuclear Receptor Coregulators in Cancer Biology
- (2009) B. W. O'Malley et al. CANCER RESEARCH
- A potential link between peroxisome proliferator-activated receptor signalling and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy
- (2009) F. Djouadi et al. CARDIOVASCULAR RESEARCH
- Efficacy and safety of muraglitazar: a double-blind, 24-week, dose-ranging study in patients with type 2 diabetes
- (2009) Cindy J. Rubin et al. Diabetes & Vascular Disease Research
- Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin Over 4 Years Despite Greater Weight Gain: Observations from A Diabetes Outcome Progression Trial (ADOPT)
- (2009) S. E. Kahn et al. DIABETES CARE
- Who’s in charge? Nuclear receptor coactivator and corepressor function in brain and behavior
- (2009) Marc J. Tetel et al. FRONTIERS IN NEUROENDOCRINOLOGY
- INT131: A Selective Modulator of PPARγ
- (2009) Alykhan Motani et al. JOURNAL OF MOLECULAR BIOLOGY
- Distinct modulation of voltage-gated and ligand-gated Ca2+currents by PPAR-γ agonists in cultured hippocampal neurons
- (2009) Tristano Pancani et al. JOURNAL OF NEUROCHEMISTRY
- Effect of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study
- (2009) Robert R Henry et al. LANCET
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Minireview: Won’t Get Fooled Again: The Nonmetabolic Roles of Peroxisome Proliferator-Activated Receptors (PPARs) in the Heart
- (2009) Pamela Lockyer et al. MOLECULAR ENDOCRINOLOGY
- Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease
- (2009) Emma Robinson et al. PHARMACOLOGY & THERAPEUTICS
- Peroxisome proliferator-activated receptor gamma (PPARγ): Is the genomic activity the only answer?
- (2009) Michaela Luconi et al. STEROIDS
- Fat and Beyond: The Diverse Biology of PPARγ
- (2008) Peter Tontonoz et al. Annual Review of Biochemistry
- PPARs and the Cardiovascular System
- (2008) Milton Hamblin et al. ANTIOXIDANTS & REDOX SIGNALING
- Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats
- (2008) B.-C. Yu et al. CARDIOVASCULAR RESEARCH
- Vascular PPARγ Controls Circadian Variation in Blood Pressure and Heart Rate through Bmal1
- (2008) Ningning Wang et al. Cell Metabolism
- Direct antiatherosclerotic effects of PPAR agonists
- (2008) Karin AM Jandeleit-Dahm et al. CURRENT OPINION IN LIPIDOLOGY
- Improvement of glycaemic and lipid profiles with muraglitazar plus metformin in patients with type 2 diabetes: an active-control trial with glimepiride
- (2008) Cindy J Rubin et al. Diabetes & Vascular Disease Research
- Peroxisome proliferator-activated receptors (PPARs) and their agonists for hypertension and heart failure: Are the reagents beneficial or harmful?
- (2008) Rui Chen et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The PPAR trio: Regulators of myocardial energy metabolism in health and disease
- (2008) Jose A. Madrazo et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Integration of metabolism and inflammation by lipid-activated nuclear receptors
- (2008) Steven J. Bensinger et al. NATURE
- Urothelial Carcinogenesis in the Urinary Bladder of Rats Treated with Naveglitazar, a γ-dominant PPAR α/γ Agonist: Lack of Evidence for Urolithiasis as an Inciting Event
- (2008) Gerald G. Long et al. TOXICOLOGIC PATHOLOGY
- PPARs/RXRs in Cardiovascular Physiology and Disease
- (2008) Brian N. Finck et al. PPAR Research
- Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies
- (2008) Mark A. Deeg et al. PPAR Research
- PPARγand Apoptosis in Cancer
- (2008) Heath A. Elrod et al. PPAR Research
- The Role of PPARs in Cancer
- (2008) Keisuke Tachibana et al. PPAR Research
- Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression
- (2007) Molly S. Bray et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- PPARα: Mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators
- (2007) Frank J. Gonzalez et al. TOXICOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started